BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3118482)

  • 1. [Treatment of arterial ischemia of the extremities with intravenous infusions of nitroglycerin].
    Shcherbiuk AN; Mikhaĭlov IP; Gorbunov SN
    Sov Med; 1987; (5):112-4. PubMed ID: 3118482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S; Claeys L
    Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with ultra-high dosage fibrinolysis in arterial occlusive disease].
    Redecker M; Heinrich F; Fenn K
    Vasa Suppl; 1988; 23():182-5. PubMed ID: 3206334
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostaglandin E1 in intermittent claudication].
    Scheffler P; de la Hamette D; Rogatti W
    Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolysis for lower extremity arterial and graft occlusions. American College of Radiology. ACR Appropriateness Criteria.
    Levy JM; Duszak RL; Akins EW; Bakal CW; Denny DF; Martin LG; Van Moore A; Pentecost MJ; Roberts AC; Vogelzang RL; Kent KC; Perler BA; Resnick MI; Richie J; Becker G
    Radiology; 2000 Jun; 215 Suppl():1041-54. PubMed ID: 11037530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P; Birkel L; Grub KR; de la Hamette D
    Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
    [No Abstract]   [Full Text] [Related]  

  • 8. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
    Vaccaro E; Solitro A; Barba C
    Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H; Brodel C; Meuche C; Hellmann G; Ranft J
    Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].
    Kozlitskiĭ AP
    Vestn Khir Im I I Grek; 1982 Sep; 129(9):120-3. PubMed ID: 7147583
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transcutaneous oxygen pressure during intra-arterial infusions].
    Creutzig A; Dau D; Alexander K
    Vasa; 1984; 13(3):207-12. PubMed ID: 6485524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systolic arterial hypertension: demonstration and mechanism in obliterating arteriopathy of the lower extremities].
    Temmar M; Benetos A; Simon A; Fiessinger JN; Levenson J; Safar M
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():163-6. PubMed ID: 6810820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of patients with occlusive arterial diseases of the legs with prostaglandin E1].
    Dibirov MD
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):137-8. PubMed ID: 3222855
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duplex ultrasound measurement of hemodynamic parameters at rest and following arterial stenosis: effect of intra-arterial infusion therapy with prostaglandin E1].
    Ranke C; Creutzig A; Alexander K
    Vasa Suppl; 1989; 27():353-5. PubMed ID: 2696104
    [No Abstract]   [Full Text] [Related]  

  • 15. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of risk factors in critical extremity ischemia is important].
    Gottsäter A; Wahlberg E
    Lakartidningen; 2007 Mar 14-20; 104(11):860-4. PubMed ID: 17447582
    [No Abstract]   [Full Text] [Related]  

  • 17. Complications of thrombolytic therapy for peripheral arterial occlusions.
    Campbell WB
    Acta Chir Belg; 2001; 101(3):116-22. PubMed ID: 11501386
    [No Abstract]   [Full Text] [Related]  

  • 18. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
    Fagrell B; Lundberg G; Olsson A; Ostergren J
    Vasa; 1986; 15(1):56-60. PubMed ID: 3962459
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis in extremital arteries--indications and methods.
    Wellander E; Risberg B
    Ann Chir Gynaecol; 1995; 84(4):341-8. PubMed ID: 8687077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.